The following delegates have already registered to attend OIS@AAO.  Sign up today to be added to this growing list!

A

Ace Vision Group
Bradley Hall, Director, Clinical Research & Education
AnnMarie Hipsley, MD, Founder & CEO
Bruce Kaufaman, Consultant/Advisor
Donald Robinson, VP, Business Development

Achillion Pharmaceuticals
Anthony Gibney, EVP, Chief Business Officer
Daniel Kennedy, Executive Director, Business Development
Ben Plaster, Director, Product Management
Steven Zelenkofske, MD, EVP, Chief Medical Officer

Acucela
Ryo Kubota, MD, PhD, CEO
Jim Niebanck, Chief Commercial Officer
John Shishilla, SVP, Retinal Health Monitoring

AcuFocus
Magda Michna, PhD, Chief Global Clinical & Regulatory Affairs Officer
Yari Mitchell, Chief Business Development Officer
Sandy Selvaaggi, VP, Manufacturing & Quality Operations
Al Waterhouse, President & CEO

Adverum Biotechnologies
Mehdi Gasmi, President & Chief Scientific Officer

Aerie Pharmaceuticals
Vince Anido, PhD, Chairman & CEO
Ami Bavishi, Investor Relations
Gianluca Corbinelli, Chief Commercial Officer, Europe
Nancy Davis, Director, Global Clinical Operations
Ioana Grobeiu, Director, Medical Affairs, Europe
Tad Heitmann, MBA, Director, Corporate Communications
Evan Hockman, Product Director
Casey Kopczynski, PhD, Chief Scientific Officer
Richard Lewis, MD, Chief Medical Officer
Mike Mccleerey, VP, Portfolio Development
Kathy Mcginley, VP, Human Resources & Corp. Services
Deanne Melloy, VP, Marketing
Gary Menichini, VP, Sales
Tom Mitro, COO & President
Chong Nien, Manager, Clinical Science
Melissa Parker, Product Director
Jami Rogers, Product Manager, Rhopressa
Richard Rubino, CFO
Dale Seibt, VP, Market Access
Huan Sheng, MD, PhD, Director, Clinical Research & Drug Safety
Craig Skenes, VP, Business Development
Luis Vargas, Medical Director
Julie Whitcomb, Medical Science Liaison

Aerpio Pharmaceuticals
Stephen Hoffman, PhD, MD, CEO
Kevin Peters, MD, CSO, CMO and SVP R&D

AffaMed Therapeutics
MaryJane Rafii, PhD, MBA, Senior Vice President

AGTC
Sue Washer, President & CEO

Akorn
Regina Assaf, Director, Portfolio & Stakeholder Strategy
Ron Bruns, Executive Director, Branded Ophthalmics

Albert Einstein COM-Montefiore Med Ctr
Roy Chuck, MD, PhD, Chairman

Alcon
Stephanie Ainscow, PhD, Global Head, Commercial Solutions
Sebastien Allard, Director, Corporate Development Strategy
Charlotte Bonfield, Global Head, Executive Talent
Mike Cecil, Global Product Director, OH Innovation
Barry Cheskin, VP, Accommodating IOLs, Surgical R&D
Costin Curatu, PhD, Head, Search & Evaluation - Surgical, Business Development & Licensing
Brant Gillen, Global Product Director, Digital Health Solutions
Mark Gordon, SVP, Global Head Regulatory Affairs
Paul Hallen, Global Head, Surgical Vitreoretinal & Glaucoma
Julie Haynes, Associate Director, External Alliances Ops
Alan Landers, OD, MS, Head, Search & Evaluation Vision Care
Kendra Lohrmeyer, BD&L Operations Lead
Stephane Lucchini, Head, Search and Evaluation
Carla Mack, Global Head, Professional Affairs
Patrick Matthews, Head, BD&L Transactions
Kent McCarty, Business Development & Licensing
Vidhya Mellarkod, PhD, Head, Strategy USVC
Andy Pawson, President & GM, Global Vision Care
Matt Snakenberg, Head, Global BD&L and M&A
Shannon Spock, MPH, Head, Search & Evaluation
Jay Stark, Global Head, Surgical Visualization
Adam Szaronos, Head, Dry Eye Devices
Burton Tripathi, PhD, General Manager - TrueVision
Jason Watts, BD&L Senior Associate
Stephanie Waugh, Global Head, Ocular Health
Jason Weems, Head, Global BD&L Vision Care

Cassie Ysaguirre, Senior Legal Counsel

Aldeyra Therapeutics
David Mcmullin, Chief Commercial Officer
Christopher Pearson, VP, Commercial

Allergan
Marina Bejanian, Executive Director
Glen Curran, VP, Anterior Segment
Jag Dosanjh, SVP, US Eye Care
Doug Faunce, PhD, Executive Director, External Science & Innovation
Margot Goodkin, Executive Director, Clinical Development
Yehia Hashad, MD, Senior Vice President
David LeCause, VP, Eye Care
Charles Liu, Executive Director, Device R/D
Francisco Lopez, Executive Director, Clinical Development
Sesha Neervannan, PhD, SVP, R&D Pharmaceutical Development
C David Nicholson, PhD, Chief R&D Officer
Jai Parekh, MD, MBA, FAAO, Chief Medical Officer & VP
David Pyott, MD, Former Chairman & CEO
Baldo Scassellati Sforzolini, Senior Vice President
Michelle Senchyna, PhD, Executive Director, Clinical Development, Eye Care
Chuck Silberstein, MD, Senior Vice President
Julian Smith, Executive Director, US Portfolio Expansion
Andrew Stewart, Associate VP, US Commercial Eye Care
Ramin Valian, VP, Marketing, Interventional Glaucoma, Reimbursement & Pipeline
Dawn Gaydos, Associate VP of Specialty Eye Care

Alpine Biotherapeutics
Keith Bryant, Chief Business Officer

American Academy of Ophthalmology
Jane Aguirre, VP, Membership & Alliances
Dale Fajardo, EdD, MBA, VP, Education
Keng Jin Lee, PhD, Managing Editor
Flora Lum, MD, VP, Quality & Data Science
Todd Lyckberg, Director, Development

Amring Pharmaceuticals
Erika Geimonen, PhD, VP, Business Development

Annexon Biosciences
Douglas Love, CEO

APEC MEX
Hugo Quiroz-Mercado, MD, Chairman Translational Research

Apellis
Lukas Scheibler, PhD, CIO

Aptitude Medical Systems
Qiang Gong, Founder & COO

AsclepiX Therapeutics
Wendy Perrow, MBA, CEO

ASICO / P.S.Therapy
Ravi Nallakrishnan, Managing Director

Astellas Pharma
Mina Kikuchi, PhD, Director, Global Development Project Leader
Mari Nakabayashi, PhD, Medical Director
Masanori Yokono, PhD, Associate Director

Avedro
Rajesh Rajpal, MD, Chief Medical Officer
Jim Schuermann, Chief Business Officer
Reza Zadno, PhD, President & CEO

Avellino Labs
Eric Bernabei, Chief Sales & Marketing Officer
Thomas Kim, Chief Strategy Officer & Corporate Secretary
Lynn Kim, Chief, Staff
Dennis Kim, VP, Business Development & Financing
Gene Lee, Chairman & Founder

Aviceda Therapeutics
Mohamed Genead, MD President, CEO & Co-Founder

AxeroVision
Achim Krauss, PhD, President & CEO

Azura Ophthalmics
Yair Alster, MD, Chief Technology Officer
Hila Barash, VP, Research & Development
Charles Bosworth, Chief Medical Officer
Marc Gleeson, CEO

B

Bascom Palmer Eye Institute
Kendall Donaldson, MD, Professor of Ophthalmology
Terrence O'Brien, MD, Director, the Refractive Surgery Service

Bausch + Lomb
Yolande Barnard, VP & General Manager
Ernie Bravo, Director, Marketing
David Fisher, VP, Marketing
Joseph Gordon, President
Charles Hess, VP & General Manager, US Surgical
Robert Kissling, MD, VP, Medical Affairs
Brent Lindsey, National Sales Director

Bausch Health
Sandeep Lalit, VP, Business Development

Bayer
Rafiq Hasan, MD, Global Head, Ophthalmology

Baylor College of Medicine
Jack Holladay, MD, Clinical Professor, Ophthalmology

Beaver Visitec International
Darin Dixon, VP, Sales

Belite Bio
Irene Wang, COO

Biogen
Anne Joseph, PhD, Manager S&E

Bionic Vision Technologies
Ash Attia, CEO
Brian Gordon

BioQuest, A Diversified Search Company
Roger Anderson, Managing Director
Kim Ennis, Managing Director
Dave Mildrew, Managing Director
Peter Schineller, Managing Director

Bios Partners
Stella M. Robertson, PhD, Co-Founder

Blackstone Life Sciences
Emmett Cunningham, Jr., MD, PhD, MPH, Senior Managing Director

Bluestem Capital
Drew Doshier, Investment Associate
Jon Kirby, Senior Associate, Investor Relations
Tyler Stowater, Partner

BMC
Ranna Jaraha, Director, New Media

Boehringer Ingelheim International GmBH
Victor Chong, MD, Global Head of Medicine, Retinal Health
Andrea Giani, MD, Senior Clinical Program Leader

Boston Children's Hospital
Daniel Kohane, MD, PhD, Professor, Anesthesia

BridgeBio
Barrett Katz, MD, President & Chief Medical Officer
Sandy Mong, MD, VP, Business Development & Operations
Glenn Noronha, PhD, Chief Scientific Officer

BSM Consulting
Laurie Brown, MBA, COE, COMT, CPC, CPMA, Senior Consultant

BVI
Lars Bonefeld, VP, Global Marketing
Lindsay Ladenburg, District Manager

C

California Pacific Medical Center
Rona Silkiss, MD, Chief, Division of Ophthalmic Plastic, Reconstructive & Orbital Surgery

Carl Zeiss Meditec
Mikhail Boukhny, PhD, Head, R&D Surgical Ophthalmology
Wayne Caulder, Head, US Sales, OPT & MCS
Andrew Chang, Head, Global Sales, Ophthalmic Devices
Laurie Ferguson, Head, OPT Global Communications
Dr. Michael Kaschke, President, CEO & Labor Director
Aaron Kim, General Counsel
Amelie Koch, Head, Global Strategy
Jim Mazzo, Global President, Ophthalmic Devices
Scott Meyer, Director, Strategic Business Development
Dirk Muehlhoff, VP, Refractive Laser Business Unit
Erin Powers, VP, Medical Affairs & Professional Education
Angelo Rago, Global Head, Ophthalmic Diagnostics
Karlheinz Rein, SVP & Head, Business Sector Surgical Ophthalmology
Steve Schallhorn, MD, Chief Medical Officer
Alice Swinton, Head of Content Management
Justus Wehmer, CFO

Cativer Bio Insights
Stephen Judd, President

CavtheRx
Mike Garanzini, CEO

Center For Excellence In Eye Care
William Trattler, MD, President

Center for Sight
Eva Liang, MD, Medical Director

Central Valley Eye Medical Group
Kimberly Cockerham, MD, FACS, Adjunct Clinical Associate Professor, Stanford Department of Ophthalmology

Centro De Investigacion Sophia Sa De CV
Alejandro Espinosa Lopez, LIC, Strategic Business Manager

Charles Retina Institute
Steve Charles, MD, Founder & Chairman

Chengdu Kanghong Pharmaceutical Group
Li Liu, PhD, Associate Director, Corporate Development
Fang Zhang, Corporate Development Manager

ChiralLogic
Joshua Parks, Founder

CHU Clermont Ferrand
Hayette Rebika, MD, Ophthalmologist

Clarion Healthcare
Carol Kearney, Managing Director

Claris Bio
Anton Atwell, President & CEO

Clearside Biomedical
Charlie Deignan, CFO
Rick McElheny, VP, Corporate Development

ClearView Healthcare Partners
Debbie Zhuang, Managing Director

Cleveland Clinic
Arjun Sood, Vitreoretinal Surgery Fellow

Cleveland Research Company
Steve Willoughby, Senior Research Analyst

ClinOptimize
Hayley Lane, Consultant

Clinreg Consulting Services
Debe Deck, Regulatory Consultant
Judy Gordon, DVM, Regulatory Consultant
Maureen Johnson, RN, Regulatory Consultant
Lee Kram, MD, MSE, Regulatory Consultant

Columbia University
Stephen Trokel, Professor

Compact Imaging
Don Bogue, CEO

Consulting and Marketing
Joel Gaslin, EVP, Sales & Marketing

Contract Lasik Provider
James Rynerson, MD, CEO

CooperVision
Paul Chamberlain, Director, Research Programs, R&D
Nancy Keir, Senior Director, Program & Biological Sciences, R&D
Percy Lazon, PhD, Director
John McNally, Senior Director, Clinical Research, R&D

CorneaGen
John Guckes, Senior Advisor
Howard Mendelsohn, CFO
Monty Montoya, President & CEO
Bob Stevens, CTO
James Wachtman, CCO
Jim Wachtman, Chief Commercial Officer

CVG
Chris Moore, President

D

Dalton & Associates
Michelle Dalton, Founder & President

Department of Ophthalmology, Gachon University Gil Medical Center, Incheon, Korea
Dong Heun Nam, MD, PhD, Professor

Diabetes Eye
Anil Goyal, MD, Physician

Dompé
Georgea Pasedis, PharmD, Head, Medical Affairs

Drusolv Therapeutics
John Edwards, CEO

Dry Eye and Cornea Treatment Center
Steven Maskin, MD, Founder and Inventor

Durrie Vision
Daniel Durrie, MD, Founder & Physician

E

East West Eye Institute
James Masunaga, CFO

Eloxx
Susan Schneider, MD, SVP Clinical Development, Ophthalmolgy

Emmecell
Noelia Kunzevitzky, PhD, COO

Eversight
Onkar Sawant, PhD, Director of Research

Evolve Therapeutics
Donald Fishbein, President

EW Healthcare Partners
William Andrews, Partner

ExoVision Biosciences
Brad Webb, PhD, CEO

Eyedaptic
Jay Cormier, CEO

EyeGate Pharma
Stephen From, CEO

Eyenovia
Storm Charbonneau, Commercial Operations, Manager
Tsontcho Ianchulev, MD, CEO & CMO
Michael Rowe, VP, Marketing

EyeQ Research
Michael Lachman, President

Eyevensys
Ronald Buggage, MD, Chief Medical Officer
Patricia Zilliox, PhD, CEO & President

F

Flying L Partners
William Link, PhD, Managing Director

ForSight Labs
K. Angela Macfarlane, Managing Partner

Foulkes Vision Institute
Richard Foulkes, MD, Director

Foundation Fighting Blindness
Todd Durham, VP, Clinical & Outcomes Research
Rusty Kelley, VP, Investments & Alliances
Jason Menzo, Chief Operating Officer
Benjamin Yerxa, CEO

Foundation for Ophthalmology Development, Poznan, Poland
Andrzej Grzybowski, MD, PhD, Head

F-Prime Capital
Lucille Conroy, MD

G

Ganot Capital
Guy Katsav, Managing Director, Healthcare Investments

Gebauer Medizintechnik GmbH
Steffen Gebauer, Managing Director
Peter Klopotek, PhD, CTO
Peter Litman, CEC

Genentech
Hao Chen, PhD, Senior Clinical Scientist
Phillip Lai, MD, Senior Medical Director
Shriang Ranade, PhD, Technical Development
Eric Strauss, MD, Lead Group Medical Director

Gensight-Biologics
Julio Benedicto, VP, Marketing
Laure Blouin, Clinical Analyst
Isabelle Scarabin, Business, Development Director
Magali Taiel, VP, Clinical Development

Glaucoma Research Foundation
Thomas Brunner, President & CEO

Glaucoma Specialists of San Francisco
Iryna Falkenstein, MD

Glauconix Biosciences
Kim Southern, Chief Operating Officer
George Torrejon, Senior Director, Operations & Business Development

Glaukos Corporation
Jane Rady, SVP, Corporate Strategy & Business Development

Global Research Management
Lucy Bataneant, MD, Clinical Research Director
Sherif El-Harazi, MD, MPH, President

Gray Communications
Michele Gray, Principal

Graybug Vision
Fred Guerard, CEO
Daniel Salain, COO
Charles Semba, MD, Chief Medical Officer

Gyroscope Therapeutics
Susan Hill, PhD, Chief Business Officer
Forbes Huang, VP, Business Development

H

Haffey & Co.
Bernie Haffey, President

HanAll Biopharma
Hyeakyung Ahn, Head, BioResearch Center
Joo Hyun Chae, Program Manager
Youngju Kim, Director, HPI
Minjae Shin, Alliance Advisor

Harvard Ophthalmology
Sunil Chauhan, PhD, Associate Professor

Heidelberg Engineering
Kfir Azoulay, VP & Head, Corporate Strategy

Horowitz Group
Jason Tester, CFO

Hovione
Courtney Smith, Director, Business Development & Licensing

Hoya
Rakhi Jain, PhD, VP, Global Research & Development

Hyogo Prefectural Amagasaki General Medical Center
Hideyasu Oh, MD, PhD

I

iCandy Consulting
Candace Simerson, FASOA, COE, President & CEO

Icare Finland Oy
Rami Haulisto, R&D Manager

ICON Eye Care
James Fox, MD

IDDI
Linda Danielson, COO & EVP
Sophie De Gronckel, Project Manager

ILSUNG Pharmaceuticals
Minyoung Jung, PhD, Director

Indiana University School of Medicine
Louis Cantor, MD, Chair & Professor
Alon Harris, MS, PhD, FARVO, Professor, Ophthalmology

InFocus Capital Partners
Robert Rothman, MD, Managing Partner
Ron Weiss, MD, Managing Partner

InFocus Clinical
Brad Doerschuk, President, CEO

Inova Fairfax
Michael Ross, MD

Institut de la Màcula, and Barcelona Macula Foundation
Jordi Monés, MD, PhD, Director

Interface Biologics
Wendy Naimark, PhD, VP, R&D
Tom Reeves, President & CEO

Invus Opportunities
Ron Bache, Operating Partner

IOPtima Ltd.
Ronen Castro, CEO

IQVIA
Amy Del Medico, Ophthalmology CoE Co-Chair

Iris Pharma
Yann Quentric, MSc, President

iVeena Delivery Systems
Michael Burr, VP, Product Development

Iveric bio
Adrienne Graves, PhD, Independent Director
David Guyer, MD, Executive Chairman

J

Janssen
Pete Adamson, VP & Global Head Retinal Disease Area Stronghold Ophthalmology
Eddy Anglade, MD, Vice President
Thomas Gustafson, VOP-CVM Innovation
Sarah Brennan, VP, Business Development & Licensing, CVM
Penny Fleck, VP, CVM Portfolio & Retinal Development
James List, Global Therapeutic Area Head, Cardiovascular & Metabolism

Johns Hopkins Technology Ventures
Amy House, Associate Director, Corporate Partnerships

Johns Hopkins University School of Medicine, Wilmer Eye Institute
Peter McDonnell, MD, William Holland Wilmer Professor & Director

Johnson & Johnson Vision, Surgical
Caroline Blackie, OD, PhD, Medical Director, Ocular Surface Disease
Leonard Borrmann, Head, External Innovation
Christian Cuzick, CFO, Surgical
Allie Holmes, Director, Comms & Public Affairs
Alex Gorsky, Chairman & CEO
Ken Kadziauskas, Director, Upstream Marketing, Surgical
Biren Mehta, VP, Business Development, CSS Franchise and Vision
Rich Minevich, Senior Manager, Business Development
Shlomi Nachman, CGC, CSS Franchise and Vision
Callie Parker, Strategic Support Director
MK Raheja, PhD, MBA, Head of R&D, Ophthalmic Platform
Tom Ruggia, VP, Customer Experience, Surgical
Brian Schwam, MD, Senior Director, External Innovation & Medical Science Strategy
Nick Tarantino, OD, Head, Global Clinical Sciences
Prabhu Velusami, MD, New Ventures & Transactions Lead, Vision
Nivine Woods, Director, Global Marketing, Surgical
Troy Wu, MD, Senior Director, Business Development
Jonathan Talamo, MD, Chief Medical Officer & Worldwide VP, Medical & Clinical Affairs

K

Kala Pharmaceuticals
Todd Bazemore, COO
Kim Brazzell, MD, PhD, Chief Medical Officer
Hongming Chen, Chief Scientific Officer
Mark Iwicki, Chairman & CEO
Niranjan Kameswaran, VP, Strategy
Kate Kline, VP, Marketing
Sarah Watson, Senior Director, Market Access Strategy
James Yanek, Director, Professional Relations
Steven Zhang, MD, PhD, VP, Medical Affairs

Kaleidoscope Innovation
Benjamin Ko, Engineering Manager

Kedalion Therapeutics
Casey Dougan, VP, Corporate Development
Peter Noymer, PhD, CEO

Keio University School of Medicine
Kazuo Tsubota, MD, PhD, FARVO, MBA, Professor and Department Chair

KKR
Arjun Arora, Principal
Kal Rao, Associate
Roger Sawhney, MD, Director, Healthcare

Knight Therapeutics
Winston Karges, Manager, Business Development

L

LaserVue Eye Center
Jay Bansal, MD, Medical Director

LayerBio
Kenneth Mandell, MD, PhD, CEO

LENSAR
Nick Curtis, President & CEO

Lentechs
Robin Sears, CEO

Leo Lens Technology
Kenny Key, COO & General Counsel

Lexitas
Saiid Davari, VP, Investigator Relations
Chad Ice, CEO
Michael Schiewe, Director, Business & Site Development

Lifecore Biomedical
Kipling Thacker, PhD, Chief Scientific Officer & VP

Lightstone Ventures
Anne Rubin, Entrepreneur-in-Residence

Lion VisionGift
Corrina Patzer, Chief Strategy Officer

London Vision Clinic - Retina
Paulo Eduardo Stanga, MD, Consultant Ophthalmologist & Lead Vitreoretinal Surgeon

Long Beach Eye Care Associates
Donald Schwartz, MD, Physician

Lubrizol Advanced Materials
Carey Boyum, Key Account Manager

LumiThera
Clark Tedford, PhD, President & CEO

Lynthera Corporation
Caesar Luo, MD, CTO

M

Mark Packer MD Consulting
Corinne Packer, Treasurer
Mark Packer, MD, President

Market Scope
Kristen Ingenito, Vice President

Massachusetts Eye & Ear
Bonnie Brodowski, Director, Corporate & International Development
Reza Dana, MD, Claes H. Dohlman Professor, Ophthalmology
Joan Miller, MD, Chief & Chair, Ophthalmology

Matossian Eye Associates
Cynthia Matossian, MD, Founder & Medical Director

McDermott & Bull Executive Search
Jake Vander Zanden, Technology & Life Science Practice Leader

Medicel
Thomas Seitz, MBA, VP, Sales

Merck
Vanitha Sekar, PhD, Executive Director of BD&L

MGDinnovations
Katey Mulfinger, VP of Operations and Marketing

Microbiotix
Terry Bowlin, PhD, CEO
Richard Gauthier, Chief Business Officer

MojoVision
Ashley Tuan, OD, PhD, VP, Medical Devices

Moose Jaw Ophthalmology
Matthew Regan, MD

N

Neovista Eye Institute
Andre Romano, MD, Medical Director

Neurotech Pharmaceuticals
Rich Small, CEO

Nevakar
Raul Trillo, Chief Commercial Officer
Edward Tykot, VP, Business Development

New England Eye Center
Caroline Baumal, MD
Jay Duker, MD, Director

New York Eye and Ear Infirmary of Mount Sinai
James Tsai, MD, MBA, President

NHPL
Kamakshi Sharma, Senior Analyst

Nitto Medic
Kunihiko Shiina, Executive Advisor

Notal Vision
Grace Chang, MD, PhD, Chief Medical Officer
Kester Nahen, PhD, Chief Commercial Officer
Susan Orr, OD, CEO

Novaliq GmbH
Schlueter Oliver, Managing Director, CFO
Christian Roesky, PhD, Managing Director & CEO

Novartis
Arthur Ciociola, PhD, VP, Global Franchise Head Regulatory Affairs Ophthalmology
Usha Gutti, Manager
Knut Sturmhoefel, Head BD&L Ophthalmology
Nikolaos Tripodis, Worldwide Franchise Head Ophtha

Noveome Biotherapeutics
David Steed, MD, EVP, Clinical Affairs & Chief Medical Officer
Patrick Welch, MBA, Director

Novo Ventures
Ken Harrison, Principal

O

OcuFLOW
Theresa Kramer, MD, MBA, Ophthalmic Pathologist

Ocular Instruments
Phil Erickson, President
Ray Graham, Director Engineering & Research

Ocular Surgery News & Healio
Scott Wright, Sales Director

Ocular Therapeutix
Bindu Manne, Director, Market Development
Christopher White, SVP, Corporate Development

Oculis
Riad Sherif, MD, CEO

Oculos Clinical Research
Benjamin Burton, President & CEO

Ocuphire Pharma
Mina Sooch, MBA, CEO

OD-OS GmbH
Winfried Teiwes, CEO & Managing Director

OHSU Casey Eye Institute
Brandon Lujan, MD, Associate Professor

Okogen
Eric Daniels, MD, COO
Quinton Oswald, Director

OIS Press
Steve Lenier, Managing Editor

Okogen
Brian Strem, CEO

Omar Consulting Group
Cheryl Rowe-Rendleman, PhD, CEO & Managing Consultant

Omeros Corporation
Tim Duffy, VP, Business Development
Rahim Hirji, Director, Marketing

ONL Therapeutics
David Esposito, CEO

Oppenheimer & Company
Esther Rajavelu, Executive Director

Optceutics
Chris Redhead, PhD, CEO

Ora
Ryan Bouchard, VP, Medical Devices
Susan Francia, Business Development
James Golando, Chief Operating Officer
Jeanne Hecht, Chief Strategy Officer
Lisa Jennings, Senior Director, Global Alliance Business Development
Keith Lane, Senior Director
Aron Shapiro, SVP & Chief Commercial Officer

OrbiMed
Anat Naschitz, Managing Director

Outlook Therapeutics
Terry Dagnon, COO
Jeff Evanson, Chief Commercial Officer
Jennifer Kissner, PhD, SVP, Clinical Development

Oxurion
Thomas Clay, Chairman
Andy De Deene, MD, Global Head Development
Patrik De Haes, MD, CEO
Jean Feyen, PhD, Chief Scientific Officer
Wouter Piepers, Global Head Investor Relations & Corporate Communications
Dominique Vanfleteren, Chief Financial Officer
Vinciane Vangeersdaele, Chief Commercial Officer

Oyster Point Pharma
Michael Ackermann, PhD, Chairman
Loni da Silva, VP, Regulatory Affairs
George Donato, VP, CMC
Dawn Koffler, VP, Marketing
Daniel Lochner, CFO
Jeffrey Nau, PhD, President & CEO
Kristen Striffler, Associate Director, Clinical Development

P

P&T Magazine
Peter Sonnenreich, Editor

Palo Alto Investors
John Doux, Investor

Panoptes Pharma
Franz Obermayr, CEO

PentaVision
Jennifer Ford, Senior Managing Editor, Retinal Physician & Glaucoma Physician Magazines

Perfect Lens
Steven Smathers, President

Pharmaceutical Product Evaluation
Pierre Paul Elena, PhD, Chief Scientific Officer

pH-Pharma
Jenny Song, Preclin Oph Lead

Piper Jaffray
J.P. Peltier, Managing Director, Global Head, Healthcare Investment Banking

Pivotal bioVenture Partners
Robert Hopfner, Managing Partner
Ash Khanna, PhD, Venture Partner
Heather Preston, MD, Managing Partner

PIXIUM VISION
Lloyd Diamond, CEO
Didier Laurens, CFO

PLS
Suresh Pemmaraju, Manager

PolyActiva
Russell Tait, CEO
Vanessa Waddell, Head, Commercial Operations & Business Development

PPD
Jaime Garvey, Director Clinical Team Management
Rodney Hill, Director of Project Management, Ophthalmology Pillar
Tracey Roberts, Senior Director, Global Project Management

PRA Health Sciences
Maria Yankova, MD, MBA, MPH, Medical Director Ophthalmology

Pres-By Vision
Barak Azmon, MD, Director

Prisma Eye Institute
Alan Leahey, MD, Ophthalmologist

Promedica International
Khan Lau, OD, MBA, Director, Clinical Operations
Shannon Stoddard, President & CEO

Proqr Therapeutics
Aniz Girach, MD, Chief Medical Officer

Pureos
Dominik Escher, Partner

R

RA Capital Management
Zach Scheiner, Principal
Laura Stoppel, Associate

Refocus-Group
Mike Judy, President & CEO

Regenera Pharma
Alon Netser, CFO
Jordan Rubinson, CEO

Regeneron Pharmaceuticals
Muna Bitar, PharmD, Associate Director, Ophthalmology, Medical Affairs
Carmelo Romano, PhD, Executive Director, Ophthalmology
Jonathan Weyne, MD, Senior Director, Clinical Development

REGENXBIO
Anya Derbij, Senior Director

Retina Associates of Cleveland
Lawrence Singerman, MD, FACS, Founder

Retina Consultants of Houston
Charles Wykoff, MD, Director of Research

Retina Research Center
Brian Berger, MD, President

Retinagenix/BridgeBio
Houman Hemmati, MD, PhD, Clinical Development

Retinal Consultants of Arizona/Retinal Research Institute
Pravin Dugel, MD, Managing Partner

Retinal Consultants of AZ
Derek Kunimoto, MD, JD

Retina-Vitreous Associates Medical Group
David Boyer, MD, Senior Partner

Review of Ophthalmology/Review of Optometry
Michele Barrett, Manager
Walter Bethke, Editor in Chief

Rimonci
Richel Liu, CEO

RxSight
Ilya Goldshleger, VP, Engineering
Alex Huang, CEO
Eric Weinberg, Chief Commercial Officer

S

Santen
Robert Bauer, Director, Business Development EMEA
Frank Chen, Corporate Ventures
Tsuyoshi Chiwata, Associate Director, US Business Development and Venture Management
Takeo Hirose, Vice President
Jean Kim, PhD, Venture Capital Analyst
Rocky Kuroki, Manager, US Business Development
Mari Nakajima, Coordinator
Peter Sallstig, MD, SVP, Head, Product Development, Global R&D

SB Strat Dev Consultants
Sharon Bakalash, MD, PhD, Founder & CEO

Scheie Eye Institute at UPenn
Joan O'Brien, MD, Chairman

Schepens Eye Research Institute
Hidenaga Kobashi, MD, Clinical Fellow

Shore Research & Development
John Hall, President

Shire (A Takeda Company)
Robert Dempsey, Head, Global Ophthalmology Franchise
Scott Hunter, Global Marketing Lead - Ophthalmics
Beth Marsh, Global Product Strategy Lead

SightGlass Vision
Tom Chalberg, PhD, Founder & CEO
Michael Fertik, Founder & Chief Strategy Officer
Joseph Rappon, Chief Medical Officer

SightLine Partners
Buzz Benson, Managing Director

Singapore Eye Research Institute
Danny Belkin, PhD, MBA, Director, Technology Development & Commercialization
Denise Teoh, Senior Manager

Smartlens
Savas Komban, CEO

SMI Holding
Eberhard Schmidt, Managing Director

Soho BioConsulting
Jinzhong Zhang, PhD, Principal

Spark Therapeutics
Dustin Shilling, New Product Planning, Senior Associate

Square 1
Lauren Gyoerkoe, Founder & Strategist

STAAR Surgical
David Friess, OD, VP, North America Clinical Strategy & Professional Affairs

Stealth BioTherapeutics
Brian Hotchkiss, Head, Business Development & New Product Planning

Strategic Intelligence
Babak Nemati, PhD, President & CEO

Stuart Therapeutics
Bob Baratta, MD, Chairman & CMO
Eric Schlumpf, President & CEO

Summit Rock Strategy Consulting
Sandra Ruggles, PhD, President

Sun Ophthalmics
Ryan Bleeks, National Sales Director
Ryan Brown, Associate Director, Professional Relations
Pat Fetaya, Senior Director, Business Development & Strategy
Mark Hagler, SVP, Head Ophthalmic
Abayomi Ogundele, Senior Director, Ophthalmology Medical Head, Medical Affairs
Drew Parks, Director, Professional Relations

Sydnexis
Patrick Johnson, PhD, Chief Business Officer
Kenneth Widder, MD, CEO

Syneos Health
Laszlo Bekesi, MD, VP, Clinical Development Ophthalmology
Kathleen Fanning, Senior Director, Operations
Nicholas Spittal, SVP, Clinical Development
Stacey Stein, Director, Business Development, Medical Devices & Diagnostics

T

Taejoon Pharmaceutical
Joon Youb Lee, CEO

Take One Productions
Aaron Keller, Videographer & Editor
Russell Welch, Editor

Tarsius Pharma
Daphne Langford, PhD, CEO

Tarsus Pharmaceuticals
Bobby Azamian, MD, PhD, CEO

Tauber Eye Center
Joseph Tauber, MD

TearClear
Philip Gioia, Commercial Operations
Rick Heinick, Chairman
Kevin Hershfield, CEO
Srini Venkatesh, CSO

TFG Education
Brad Fundingsland, President
Rebecca Winter, Global Business Development

The Cooper Companies
Kelly Tran, Senior Corporate Development Analyst

The Eye Associates
Cathleen McCabe, MD, Medical Director

The Macula Center
Michael Tolentino, MD, Partner

The Magnum Group
Randy Mcdonald, Business Development Consultant

The New York Eye & Ear Infirmary
Robert Ritch, Surgeon Director & Chief, Glaucoma Services

The Ophthalmologist
Phoebe Harkin, Deputy Editor

Thea Laboratories
Jean Chibret, President
Colin Francou, Business Development Manager
Celine Olmiere, Scientific Manager

Thea Open Innovation
Anne De Brugerolle, Business Development Manager

Thea Pharmaceuticals
Susan Benton, General Manager & Head, U.S.

Third Rock Ventures
Jeff Finer, PhD, Venture Partner
George Xu, PhD, Venture Associate

TissueTech (Bio-Tissue)
Timothy Gilbert, Senior Manager, Professional Relations & Education
Andrew Jones, Associate VP, Marketing
Shrikant Rahalkar, VP, Marketing

TopiVert
Ajay Duggal, Chief Medical Officer
Martyn Foster, Chief Scientist
Anuj Madhok, Chief Business Officer
Steve Webber, PhD, Chief Scientific Officer

Tracery Ophthalmics
Chris Bott, Senior Adviser
Shelley Boyd, MD, President & CEO

Trefoil Therapeutics
David Eveleth, CEO
Schalon Newton, DM, Chief Business Officer

Tsubota Laboratory
Yoichi Horiba, Manager, Sales Team

U

Unither Pharmaceuticals
Josh Myers, Business Development Manager

University Hospital Bern
Marion Munk, MD, PhD,

University of Arizona College of Medicine
Brennan Boyd

University of California Irvine
Mitul Mehta, MD

University of California, San Diego
Robert Weinreg, MD, Chair & Distinguished Professor, Ophthalmology

University of Michigan
David Zacks, MD, PhD, Physician

University of Pennsylvania
Alexander Brucker, MD, Professor of Ophthalmology

University of Wisconsin-Madison
Paul Kaufman, MD, Professor Emeritus of Ophthalmology

UPike College of Optometry/Kentucky Eye Institute
Paul Karpecki, OD, Associate Professor

V

Valley Retina Institute
Victor Gonzalez, MD, CEO

Valley Retina PC
Shihwa Chang, MD, CEO

Vance Thompson Vision
Vance Thompson, MD, Director, Refractive Surgery

Vance Thompson Vision/Equinox/Expert Opinion
John Berdahl, MD, Surgeon & Partner

Vantage Eye Care
Mark Blecher, MD, Managing Partner, Philadelphia Eye Division

Vedere
Cyrus Mozayeni, MD, CEO

Veloce BioPharma
Samuel Barone, MD, Chief Medical Officer

Venrock
Harry Barber, MBBS, Portfolio Manager

Vensana Capital
Kirk Nielsen, Managing Partner
Cynthia Yee, Principal

Verana Health
Bill Abbott, Business Development Executive - Clinical Trails
Donald Butler, VP, Commercial & Clinical Trials
Karim Damji, VP, Head of Product
Hylton Kalvaria, VP, Strategic Partnerships
Miki Kapoor, CEO
Chet Kumar, VP, Life Science & Commercial

Vertical Pharmaceuticals
Lata Handiwala, PharmD, Director of Medical Affairs
David Jacobs, MD, VP, Clinical Development and Medical Affairs
Michelle Manzo, MPH, Medical Science Liaison
Brian Markison, CEO
JD Schaub, Chief Operating Officer

Vestrum Health
Nadeem Ahmad, COO
Tom Brogan, CEO

Virginia Eye Consultants
John Sheppard, MD, President
Elizabeth Yeu, MD, Partner

Visant Medical
Vartan Ghazarossian, PhD, President & CEO

Vision CRC
Arthur Back, PhD, Managing Director

Vision Ophthalmic Development International
Rhett Schiffman, MD, MS, MHSA, President & CEO

Visionary Venture Fund
Garrett Hamontree, Principle
Jeffry Weinhuff, Managing Partner

VisionCare
Steve Denelsky, Board Member
Blake Michaels, President & CEO
Wolfgang Tolle, Board Chairman

VISUfarma BV
Keren Leshem, VP, Corporate Development
Thomas Van Haarlem, MD, CEO

VRM Consultants of New York
K. Bailey Freund, Clinical Professor

W

Warrenville EyeCare & LASIK
Lisa Nijm, MD, JD, Founder & Medical Director

WCCT Global
Yosuke Izumi, Director, Business Development
Oriana Lewallen, Associate Director, Project Management

Wills Eye Hospital
Christopher Rapuano, MD, Chief, Cornea Service

Wisconsin Alumni Research Foundation
Michael Partsch, Chief Venture Officer

Y

Yale University School of Medicine
Lucian Del Priore, MD, PhD, Professor & Chair, Department of Ophthalmology and Visual Science

Yelroc Consulting
Andy Corley, Principal

#

2CTech
James Taylor, CEO